首页 | 本学科首页   官方微博 | 高级检索  
检索        

梗阻性肥厚型心肌病化学消融术治疗进展
引用本文:林琳,张翠丽,富路.梗阻性肥厚型心肌病化学消融术治疗进展[J].心血管病学进展,2007,28(2):288-289.
作者姓名:林琳  张翠丽  富路
作者单位:哈尔滨医科大学第一临床医学院心内科,黑龙江,哈尔滨,150001
摘    要:梗阻性肥厚型心肌病(HOCM)是以室间隔非对称性肥厚、左室流出道狭窄,并由此引起梗阻症状为特点的心肌病。降低左室流出道压差是临床治疗有症状HOCM患者的目标,经皮经腔室间隔心肌化学消融术是一种很有前景的介入治疗方法,创伤小、安全性高,并能取得与外科手术同样的疗效。

关 键 词:梗阻性肥厚型心肌病  化学消融术  介入治疗
文章编号:1004-3934(2007)02-0288-02
修稿时间:2006-04-25

Advances in Treatment of Hypertrophic Obstructive Cardiomyopathy by Percutaneous Transluminal Septal Myocardial Ablation
LIN Lin,ZHANG Cui-li,FU Lu.Advances in Treatment of Hypertrophic Obstructive Cardiomyopathy by Percutaneous Transluminal Septal Myocardial Ablation[J].Advances in Cardiovascular Diseases,2007,28(2):288-289.
Authors:LIN Lin  ZHANG Cui-li  FU Lu
Institution:Department of Cardiology, The First Clinical College of Harbin Medical University, Harbin 150001, China.
Abstract:Hypertrophic obstructive cardiomyopathy is characterized by asymmetric hypertrophy of the interventricular septum,a narrowed left ventricular outflow tract and the related symptoms.Percutaneous transluminal septal myocardial ablation is a promising intervention procedure introduced in recent years,which involves minimal injury,and has a high level of safety and the same effectiveness as surgical procedure.
Keywords:hypertrophic obstructive cardiomyopathy  catheter ablation  intervention
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号